Breaking News Instant updates and real-time market news.

NKTR

Nektar

$48.80

0.87 (1.82%)

13:45
10/12/18
10/12
13:45
10/12/18
13:45

Nektar has a conference call hosted by JPMorgan

JPMorgan Analyst Fye will host a conference call with Steve Doberstein, Chief R&D Officer, CSO Jonathan Zalevsky, and Jennifer Ruddock, SVP IR and Corporate Affairs on October 12 at 2 pm.

  • 12

    Oct

  • 19

    Oct

  • 07

    Nov

  • 10

    Nov

NKTR Nektar
$48.80

0.87 (1.82%)

08/09/18
MZHO
08/09/18
NO CHANGE
Target $103
MZHO
Buy
Nektar to report additional data in coming months, says Mizuho
Mizuho analyst Difei Yang reiterates a Buy rating on Nektar Therapeutics with a $103 price target following last night's Q2 results. Data readouts of NKTR-214 remain the main catalyst for the shares, Yang tells investors in a research note. She points out that management expects to present data at a number of conferences in the coming months, including melanoma data at the Society for Immunotherapy of Cancer on November 7-11. While details on additional data in other indications "were sparse," data should be announced over the coming six-to-eight months, Yang contends.
08/08/18
PIPR
08/08/18
NO CHANGE
Target $125
PIPR
Overweight
Nektar offered more 'granularity' on PIVOT data timing, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren kept his Overweight rating and $125 price target on Nektar after its Q2 earnings beat, saying the management has also offered more detail on the company's data release plans. The analyst sees the 1L melanoma cohort readout coming before the end of 2018, followed by RCC and bladder cancer data likely in the first half of 2019 and other tumor types later next year. Van Buren adds that these disclosures should hopefully add to the company's understanding about the efficacy of 214+nivo combination therapy.
07/31/18
HCWC
07/31/18
NO CHANGE
Target $54
HCWC
Neutral
Nektar approval for NKTR-181 likely priced in, says H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay said he expects approval and a potential Class 3 scheduling or better for NKTR-181 by its PDUFA action date of May 29, 2019, but he also believes this is already priced into the stock at current levels. The future of Nektar remains leveraged to NKTR-214 and he expects the stock to be range-bound in the near-term given there is no interim updates on 214 expected until a meeting in November. An ORR above 60% would be a prerequisite for both melanoma and RCC for 214 to have "a clear shot at a Phase 3 win in the frontline I/O naive setting," but this is not a given based on the ASCO update, Chattopadhyay tells investors. He keeps a Neutral rating on Nektar shares.
07/25/18
PIPR
07/25/18
NO CHANGE
Target $125
PIPR
Overweight
Piper reiterates $125 price target on Nektar following management meeting
During recent meetings with management, it was a relief to hear of Nektar Therapeutics' "refined approach" to presenting data moving forward, Piper Jaffray analyst Tyler Van Buren tells investors in a research note. Further, the analyst came away with increased confidence in the future updated response rates for melanoma and renal cell carcinoma, which he hopes to receive in the fall. He reminds investors that NKTR-214 is now the only remaining immuno-oncology combo candidate in late-stage clinical development targeting an addressable market "that should soon surpass $30B in sales." The recent aggressive pullback in Nektar shares "presents an interesting long opportunity," Van Buren tells investors in a research note. He reiterates an Overweight rating on the stock with a $125 price target. Nektar closed yesterday down $2.91 to $46.46.

TODAY'S FREE FLY STORIES

HBAN

Huntington Bancshares

$13.66

-0.54 (-3.80%)

09:27
10/23/18
10/23
09:27
10/23/18
09:27
Hot Stocks
Huntington Bancshares to make targeted investments in people, technology »

Says local economies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

YMAB

Y-mAbs Therapeutics

$22.00

0.02 (0.09%)

09:27
10/23/18
10/23
09:27
10/23/18
09:27
Hot Stocks
Y-mAbs Therapeutics receives recommendation from COMP for OMPD for naxitamab »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$6.84

0.02 (0.29%)

09:26
10/23/18
10/23
09:26
10/23/18
09:26
Upgrade
Snap rating change  »

Snap upgraded to Positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 07

    Nov

PINC

Premier

$45.14

0.34 (0.76%)

09:26
10/23/18
10/23
09:26
10/23/18
09:26
Hot Stocks
Adventist Health engages Premier in strategic supply chain initiative »

Adventist Health is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRPX

Therapix Biosciences

$4.39

0.08 (1.86%)

09:26
10/23/18
10/23
09:26
10/23/18
09:26
Hot Stocks
Therapix Biosciences to be acquired by FDS Pharma in $48M stock deal »

FSD Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$33.52

-0.77 (-2.25%)

09:25
10/23/18
10/23
09:25
10/23/18
09:25
Technical Analysis
Technical Take: Applied Materials drops to new 52-week low, analyst action »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GFF

Griffon

$14.50

0.04 (0.28%)

09:24
10/23/18
10/23
09:24
10/23/18
09:24
Hot Stocks
Griffon subsidiary awarded $23.5M contract by NAVAIR »

Telephonics, a wholly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$54.96

0.07 (0.13%)

09:24
10/23/18
10/23
09:24
10/23/18
09:24
Hot Stocks
Verizon says 'confident' wireless business will continue to grow »

Says expects to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Nov

  • 13

    Nov

DSX

Diana Shipping

$3.86

0.05 (1.31%)

09:24
10/23/18
10/23
09:24
10/23/18
09:24
Hot Stocks
Diana Shipping to extend time charter contract for Electra with Uniper Global »

Diana Shipping announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$36.24

0.38 (1.06%)

, PF

Pinnacle Foods

$66.61

0.29 (0.44%)

09:23
10/23/18
10/23
09:23
10/23/18
09:23
Hot Stocks
Pinnacle Foods' shareholders approved acquisition by Conagra Brands »

Conagra Brands (CAG) and…

CAG

Conagra Brands

$36.24

0.38 (1.06%)

PF

Pinnacle Foods

$66.61

0.29 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

QCOM

Qualcomm

$66.08

0.72 (1.10%)

, AMZN

Amazon.com

$1,789.00

25.09 (1.42%)

09:23
10/23/18
10/23
09:23
10/23/18
09:23
Hot Stocks
Amazon, Qualcomm to put Alexa assistant in more headphones »

Qualcomm (QCOM) said in a…

QCOM

Qualcomm

$66.08

0.72 (1.10%)

AMZN

Amazon.com

$1,789.00

25.09 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

ACB

Aurora Cannabis

$0.00

(0.00%)

, ACBFF

Aurora Cannabis

$0.00

(0.00%)

09:22
10/23/18
10/23
09:22
10/23/18
09:22
Hot Stocks
Aurora Cannabis to commence trading on NYSE today »

Aurora Cannabis will…

ACB

Aurora Cannabis

$0.00

(0.00%)

ACBFF

Aurora Cannabis

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$261.03

0.97 (0.37%)

09:21
10/23/18
10/23
09:21
10/23/18
09:21
Recommendations
Tesla analyst commentary  »

Tesla shares could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

HAL

Halliburton

$36.36

-1.18 (-3.14%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$93.62

-0.28 (-0.30%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Hot Stocks
Medtronic announces FDA approval for Valiant Navion thoracic stent graft system »

Medtronic announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$138.68

-0.32 (-0.23%)

, ITCI

Intra-Cellular

$17.21

-1.02 (-5.60%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Conference/Events
JPMorgan pharma and biotech analysts to hold analyst/industry conference call »

Smid Cap Biotech Analyst…

JNJ

Johnson & Johnson

$138.68

-0.32 (-0.23%)

ITCI

Intra-Cellular

$17.21

-1.02 (-5.60%)

AGN

Allergan

$187.75

-1.87 (-0.99%)

SAGE

Sage Therapeutics

$118.03

-4.29 (-3.51%)

ALKS

Alkermes

$38.86

-1.34 (-3.33%)

ACAD

Acadia

$21.77

-0.46 (-2.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 19

    Dec

  • 31

    Jan

EIGR

Eiger BioPharmaceuticals

$10.65

-1.2 (-10.13%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Syndicate
Eiger BioPharmaceuticals 4.2M share Spot Secondary priced at $10.35 »

BTIG acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 23

    Oct

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
10/23/18
10/23
09:18
10/23/18
09:18
Options
Overnight activity included 825 trades in SPX and 119 trades in VIX »

825 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$31.20

-0.25 (-0.79%)

, F

Ford

$8.41

0.06 (0.72%)

09:17
10/23/18
10/23
09:17
10/23/18
09:17
Hot Stocks
Avis Budget, Ford announce agreement to connect fleet vehicles »

Avis Budget (CAR)…

CAR

Avis Budget

$31.20

-0.25 (-0.79%)

F

Ford

$8.41

0.06 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 13

    Dec

NCR

NCR Corp.

, JTPY

JetPay

$4.97

2.9 (140.10%)

09:15
10/23/18
10/23
09:15
10/23/18
09:15
Recommendations
NCR Corp., JetPay analyst commentary  »

NCR Corp. deal for JetPay…

NCR

NCR Corp.

JTPY

JetPay

$4.97

2.9 (140.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 26

    Nov

  • 29

    Nov

CADE

Cadence Bancorp

$21.65

-0.27 (-1.23%)

09:15
10/23/18
10/23
09:15
10/23/18
09:15
Recommendations
Cadence Bancorp analyst commentary  »

Cadence Bancorp price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 06

    Dec

09:15
10/23/18
10/23
09:15
10/23/18
09:15
General news
Breaking General news story  »

Minneapolis Federal…

CMP

Compass Minerals

$68.01

-0.08 (-0.12%)

09:14
10/23/18
10/23
09:14
10/23/18
09:14
Earnings
Compass Minerals sees FY18 EPS $2.20-$2.50, consensus $2.83 »

Compass Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

FITB

Fifth Third

$25.38

-0.95 (-3.61%)

09:14
10/23/18
10/23
09:14
10/23/18
09:14
Hot Stocks
Breaking Hot Stocks news story on Fifth Third »

Fifth Third says at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

HPQ

HP Inc.

$24.11

0.26 (1.09%)

09:13
10/23/18
10/23
09:13
10/23/18
09:13
Hot Stocks
HP Inc., NTU Singapore and NRF collaborate on corporate innovation lab »

Nanyang Technological…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.